 VALENCIA, Calif. and MELBOURNE, Australia, Oct. 20, 2022 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today that it will report its third quarter 2022 financial results after the close of the U.S. financial markets on Thursday, November 10, 2022. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time Friday, November 11, 2022, at 8:30 a.m. Australian Eastern Daylight Time to discuss its financial results and recent highlights. 